Rhumbline Advisers lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 202.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 599,212 shares of the medical equipment provider’s stock after buying an additional 400,920 shares during the quarter. Rhumbline Advisers owned about 0.17% of Intuitive Surgical worth $215,297,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of ISRG. Ativo Capital Management LLC grew its stake in Intuitive Surgical by 2.2% in the 3rd quarter. Ativo Capital Management LLC now owns 1,327 shares of the medical equipment provider’s stock valued at $1,319,000 after acquiring an additional 29 shares during the last quarter. Bell Investment Advisors Inc acquired a new stake in Intuitive Surgical in the 3rd quarter valued at about $29,000. Eagle Bay Advisors LLC grew its stake in Intuitive Surgical by 48.5% in the 3rd quarter. Eagle Bay Advisors LLC now owns 101 shares of the medical equipment provider’s stock valued at $101,000 after acquiring an additional 33 shares during the last quarter. Bluestein R H & Co. grew its stake in Intuitive Surgical by 3.3% in the 3rd quarter. Bluestein R H & Co. now owns 1,087 shares of the medical equipment provider’s stock valued at $1,081,000 after acquiring an additional 35 shares during the last quarter. Finally, Parcion Private Wealth LLC grew its stake in Intuitive Surgical by 3.4% in the 4th quarter. Parcion Private Wealth LLC now owns 1,109 shares of the medical equipment provider’s stock valued at $344,000 after acquiring an additional 36 shares during the last quarter. Institutional investors and hedge funds own 83.69% of the company’s stock.
ISRG has been the topic of a number of research reports. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $370.00 to $315.00 and set an “outperform” rating on the stock in a research note on Friday, January 21st. Morgan Stanley reduced their target price on shares of Intuitive Surgical from $325.00 to $300.00 and set an “equal weight” rating on the stock in a report on Monday, April 25th. StockNews.com assumed coverage on shares of Intuitive Surgical in a report on Thursday, March 31st. They issued a “hold” rating on the stock. Wells Fargo & Company reduced their target price on shares of Intuitive Surgical from $350.00 to $339.00 and set an “overweight” rating on the stock in a report on Friday, April 22nd. Finally, Wolfe Research assumed coverage on shares of Intuitive Surgical in a report on Tuesday, April 5th. They issued a “peer perform” rating and a $315.00 target price on the stock. Eight analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $326.60.
Shares of ISRG stock traded up $12.00 during trading hours on Friday, hitting $223.69. 2,250,282 shares of the company were exchanged, compared to its average volume of 2,675,108. The firm has a market cap of $80.30 billion, a PE ratio of 49.75, a PEG ratio of 4.81 and a beta of 1.26. Intuitive Surgical, Inc. has a 1 year low of $206.60 and a 1 year high of $369.69. The firm has a fifty day moving average of $269.05 and a 200 day moving average of $303.94.
Intuitive Surgical (NASDAQ:ISRG – Get Rating) last announced its quarterly earnings data on Thursday, April 21st. The medical equipment provider reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.07. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.43 billion. Intuitive Surgical had a net margin of 27.84% and a return on equity of 14.16%. The company’s revenue was up 15.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.17 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 4.14 earnings per share for the current year.
Intuitive Surgical Profile (Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.